Cite
APA Citation
Mease, P., Marzo-Ortega, H., Poder, A., Van den Bosch, F., Wollenhaupt, J., Lespessailles, E., McIlraith, M., Teng, L., & Hall, S. (n.d.). tHU0420 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in BASDAI in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials. Annals of the rheumatic diseases, 75, 341. http://access.bl.uk/ark:/81055/vdc_100135143374.0x000053